<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
x

Bioluminescent Orthotopic Syngeneics for I/O Assessment

There are limited treatment options available for hepatocellular carcinoma (HCC), which is an aggressive cancer type. Checkpoint inhibitors could be a valid new therapeutic option, which require suitable, immunocompetent models for preclinical evaluation.